Zenas BioPharma, Inc. Common Stock (ZBIO) operating margin is -12.6%
Zenas BioPharma, Inc. Common Stock (ZBIO) operating margin is -12.6% as of 2024-12-31. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full ZBIO research page for quote, filings, and the rest of the model. This satellite exists so “Zenas BioPharma, Inc. Common Stock operating margin” can rank with the actual number, then send you to /stock/zbio.